<< back to Clients

Testimonials - Pharmaceutical

Lilly

Site Exit and Closure Programme

On behalf of Eli Lilly and Company, I would like to pass on my sincere thanks for the work you undertook to get our 47 acre research and development site at Windlesham ready for sale.

Lilly confirmed the site was to be sold in January 2020 with the majority of my engineering team leaving in May 2020. This left a very small, retained team to manage the decontamination and engineering works required for the sale which was going to prove a challenge to deliver the works to the aggressive timeline of 10 months. We engaged with RVA primarily to be the project managers for work and to assume the CDM Principal Designer role but we soon discovered they had become our de facto quantity surveyor, technical advisor, safety consultant and trusted partner. The RVA project manager quickly became embedded in the team, taking a lead role in working with the retained Lilly team and the remote RVA Operations Manager to very quickly but together a comprehensive and robust tender package, take it through competitive tender and award the contract. RVA then project managed this challenging project through to successful completion and was able to deal with scope and timeline changes that came our way.

RVA’s attention to detail, commitment to safety and experience in this work was second to none and they were key to bringing in the project to time and budget, and more importantly with no accidents or near misses. Their level of rigour, including regular project meetings, contractor safety reviews and audits was impressive, and they also took on and managed other ad hoc engineering tasks to assist with the site closure.

I would highly recommend them to other companies conducting similar work.

This entry was posted in Testimonials - Pharmaceutical. Bookmark the permalink.